Bearish
Should Disc Medicine’s RALLY-MF Data and Wider Pipeline Reveal a Pivotal Inflection for IRON’s Narrative?
Disc Medicine (NASDAQ: IRON) reported a Q1 2026 net loss of US$63.5 million, emphasizing that its investment narrative increasingly hinges on clinical...